放射治疗中肿瘤控制概率的影响因素

鞠永健

放射治疗中肿瘤控制概率的影响因素

鞠永健

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 4: (183-186)

引用本文:

Citation:

放射治疗中肿瘤控制概率的影响因素

鞠永健

300192 天津, 中国医学科学院中国协和医科大学放射医学研究所

作者简介: 鞠永健(1973-),男,江苏泰兴人,博士研究生,主要从事辐射剂量学及放射治疗中肿瘤控制概率模型的研究。;

基金项目:
国家自然科学基金资助项目(39670228)
中图分类号: R144.1

The influential factors of tumor control probability in radiotherapy

JU Yong-jian

Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China
CLC number: R144.1

摘要: 可靠的肿瘤控制概率计算模型是对放射治疗方案进行准确评估的基础。所以,对肿瘤控制概率模型中所涉及的参数及对这些参数取值有影响的因素进行总结有利于提出更完善的计算模型。
- 肿瘤控制概率 /
- 放射治疗 /
- 克隆源性细胞
Abstract: The reliabie tumor control probability (TCP) model is fundamental to evaluate the effect of the protocol accurately in radiotherapy. In order to obtain the optimum TCP model, the parameters included in the model and the factors which can affect these parameters have been summarized.
- tumor control probability /
- radiotherapy /
- clonogencell
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Skladowski K, Tarnawski R, Maciejewski B, et al. Clinical radiobiology of glottic T1 squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 1999, 43:101-109.
[2]	Buffa FM and Nahum AE. Monte Carlo dose calculations and radiobiological modelling:analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control[J]. Phy Med Biol, 2000, 45: 3009-3023.
[3]	Willner J, Baier K, Pfreundner L, et al. Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma[J]. Acta Oncolica, 1999, 38:1025-1030.
[4]	Buffa FM, Fenwick JD and Nahum AE. An analysis of relationship between radiosensitivity and volume effects in tumor control probability modeling[J]. Med Phys, 2000, 27:1258-1265.
[5]	Bentzen SM and Tucker SL. Quantifying the position and steepness of radiation dose-response curves[J]. Int J Radiat Biol, 1997, 71:531-542.
[6]	Britten RA, Evans AJ, Allalunis-Turner MJ, et al. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness[J]. Racliother and Oncol, 1996, 39:145-153.
[7]	Laasonen A, Pyrhonen S, Kouri, et al. The effect of fractionated irradiation on cell kinetics[J]. Acta Oncologica, 1991, 30:51-56.
[8]	Urano M, Nishimura Y, Kuroda M, et al. Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor[J]. Radiother and Oncol, 1998, 48:221-228.
[9]	Gatti RA. The inherited basis of human radiosensjtivity[J]. Acta Oncolgica, 2001, 40:702-711.
[10]	Eastham AM, Atkinson J and West CML. Relationships between clonogenic cell survival, DNA damage and chromosomal radiosensitivity in nine human cervix carcinoma cell lines[J]. Int J Radiat Biol, 2001, 77:295-302.
[11]	Sikpi MO and Wang Y. Ionizing radiation enhances doublestrand-break repair in rapamycin-treated ataxia telangiectasia lymphoblasts[J]. Int J Radiat Biol, 2000, 76:177-187.
[12]	Wilson GD. A new look at proliferation[J]. Acta Oncologica, 2001, 40:989-994.
[13]	Jones B and Dale RG. Mathematical models of tumour and normal tissue response[J]. Acta Oncologica, 1999, 38:883-893.
[14]	Budach W, Gioioso D, Taghian A, et al. Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro[J]. Int J Radiat Oncol Biol Phys, 1997, 39:743-750.
[15]	Fowler JF. Biological factors influencing optimum fractionat ion in radiation therapy[J]. Acta Oncologica, 2001, 40:712-717.
[16]	Baumann M, Petersen C, Schulz P, et al. Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionat ed irradiation[J]. Radiother and Oncol, 1999, 50:107-111.
[17]	Baumann M, Hertz C, Baisch H, et al. Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice[J]. Radiother and Oncol, 1994, 32:137-143.
[18]	Petersen C, Zips D, Krause M, et al. Repopulation of FaDu human squamous carcinoma during fractionated radiotherapy correlates with reoxygenation[J]. Int J Radiat Oncol Biol Phys, 2001, 51:483-493.
[19]	Roberts SA and Hendry JH. The delay before onset of accelerated tumour cell repopulation during radiotherapy:a direct maximum-likelihood analysis of a collection of worldwide tumour-control data[J]. Radiother and Oncol, 1993, 29:69-74.
[20]	Thames HD, Ruifrok ACC, Milas L, et al. Accelerated repopulationduring fractionated irradiation of a murine ovarian carcinoma:downregulation of apoptosis as a possible mechanism[J]. Int J Radiat Oncol Biol Phys, 1996, 35:951-962.
[21]	Beck-Bornholdt HP, Omniczynski M, Theis E, et al. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation[J]. Acta Oncologica, 1991, 30:57-63.
[22]	Roberts SA and Hendry JH. Time factors in larynx tumor radiotherapy:lag times and intertumor heterogeneity in clinical datasets from four centers[J]. Int J Radiat Oncol Biol Phys, 1999, 45:1247-1257.
[23]	Sanchez-Nieto B, Nahum AE and Dearnaley DP. Individualization of dose prescription based on normal-tissue dosevolume and radiosensitivity data[J]. Int J Radiat Oncol Biol Phys, 2001, 49:487-499.

[1]	鞠永健 . 放射治疗中肿瘤控制概率的计算方法. 国际放射医学核医学杂志, 2000, 24(3): 138-141.
[2]	袁志斌 . ⁸⁹Sr及联合治疗转移性骨肿瘤的临床应用. 国际放射医学核医学杂志, 2005, 29(2): 53-56.
[3]	张春智 . 放射治疗诱导肿瘤细胞凋亡的近期研究动态. 国际放射医学核医学杂志, 2004, 28(6): 281-283.
[4]	施勤 , 张学光 , 强亦忠 . 细胞凋亡抑制和肿瘤细胞对放射治疗的耐受. 国际放射医学核医学杂志, 1998, 22(6): 273-276.
[5]	刘光伟 , 龚守良 . siRNA与肿瘤放射治疗. 国际放射医学核医学杂志, 2004, 28(4): 169-172.
[6]	刘英 , 陈龙华 , 巩湘浩 , 吕国士 . VEGF与肿瘤的放射治疗. 国际放射医学核医学杂志, 2003, 27(4): 183-186.
[7]	董峰 , 谭建 , 周荫保 . ³²P在肿瘤治疗中的应用. 国际放射医学核医学杂志, 1998, 22(6): 255-258.
[8]	张永权 , 刘文力 , 张庆原 . 脑血管畸形及颅内肿瘤的伽玛刀治疗. 国际放射医学核医学杂志, 2002, 26(1): 38-40.
[9]	张祥松 , 唐安戊 . PET显像在肿瘤放射治疗中的应用. 国际放射医学核医学杂志, 1999, 23(4): 159-161.
[10]	刘强 . 放射性脑损伤研究现状. 国际放射医学核医学杂志, 2004, 28(4): 178-181.